National COVID Cancer Antibody Survey

The National COVID Cancer Survey has been evaluating antibody tests in individuals living with cancer since September 2021. This survey was designed to improve understanding of the protection provided by antibodies generated following COVID-19 infection and vaccination in individuals with cancer.

Several thousand people have taken part and recruitment for this survey is now complete. We thank everyone who has participated. We are very grateful for your very positive feedback of this survey.

Analysis is in progress and we envisage we will be in a position to share our findings in due course.

Update 4/5/22- Analysis is now nearing completion. Over 4,000 tests have been analysed and we are very grateful for all those taking part.

Update 2/4/22- Thank you to all survey participants who provided feedback to UKHSA. We are extremely grateful for the very positie feedback this survey had received.

Update 22/3/22- Survey recruitment is now complete. We thank everyone for their participation and very positive feedback to date.

Update 11/1/22 – anyone with blood cancer on a watch and wait treatment plan or previously treated for blood cancer with anti-cancer drugs or a stem cell transplant can take part (see FAQs for more details).

Update 26/11- we are delighted that over 1000 people have received their results as part of this survey. The website is operational. If you have had/are having any issues with your 16 digit code or kit order, we recommend you re-request your kit.

Update 27/10- We are delighted to have helped 500 people receive their results as part of this survey.

Update 16/10- We are delighted that 250 people have received their results.

Update 11/10- We are delighted 150 people have received their kit, done their test and received results.

Update 20/09- We are delighted to be able to start welcoming people to participate in the survey. Thanks so much for your support.